Copyright
©The Author(s) 2022.
World J Clin Cases. Feb 16, 2022; 10(5): 1485-1497
Published online Feb 16, 2022. doi: 10.12998/wjcc.v10.i5.1485
Published online Feb 16, 2022. doi: 10.12998/wjcc.v10.i5.1485
Prior initial cancer site | All-cause survival (95%CI) | ||
Overall | Age < 65 yr (%) | Age ≥ 65 yr (%) | |
No prior cancer | 26.42 (25.90, 26.94) | 28.95 (28.14, 29.77) | 24.49 (23.82, 25.16) |
With prior cancer | 25.20 (23.80, 26.63) | 30.12 (26.68, 33.62) | 24.08 (22.55, 25.65) |
Prostate | 24.79 (21.39, 28.32) | 23.33 (16.23, 31.21) | 25.16 (21.35, 29.14) |
Gastrointestinal | 26.47 (23.96, 29.04) | 31.13 (22.60, 40.03) | 26.00 (23.38, 28.68) |
Hematologic | 28.06 (22.75, 33.58) | 42.17 (31.11, 52.80) | 22.16 (16.49, 28.38) |
Breast | 26.80 (22.96, 30.78) | 33.27 (25.47, 41.25) | 24.36 (20.04, 28.92) |
Genitourinary | 23.64 (20.14, 27.30) | 34.29 (25.39, 43.35) | 21.06 (17.36, 25.02) |
Lung | 19.32 (13.87, 25.45) | 12.50 (3.95, 26.23) | 20.83 (14.64, 27.79) |
Other | 22.90 (18.79, 27.26) | 24.61 (16.44, 33.66) | 22.33 (17.66, 27.35) |
- Citation: Yin X, He XK, Wu LY, Yan SX. Effect of prior malignancy on the prognosis of gastric cancer and somatic mutation. World J Clin Cases 2022; 10(5): 1485-1497
- URL: https://www.wjgnet.com/2307-8960/full/v10/i5/1485.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i5.1485